Anne C Teirlinck
Overview
Explore the profile of Anne C Teirlinck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Roekel C, Poukka E, Turunen T, Nohynek H, Presser L, Meijer A, et al.
J Infect Dis
. 2023 Nov;
229(Supplement_1):S92-S99.
PMID: 37935046
Monitoring the real-life effectiveness of respiratory syncytial virus (RSV) products is of major public health importance. This generic protocol for a test-negative design study aims to address currently envisioned approaches...
2.
McDonald S, Teirlinck A, Hooiveld M, van Asten L, Meijer A, de Lange M, et al.
Influenza Other Respir Viruses
. 2023 Jun;
17(6):e13146.
PMID: 37346096
Background: Despite the known relatively high disease burden of influenza, data are lacking regarding a critical epidemiological indicator, the case-fatality ratio. Our objective was to infer age-group and influenza (sub)type...
3.
Riccio M, Spreeuwenberg P, Osei-Yeboah R, Johannesen C, Vazquez Fernandez L, Teirlinck A, et al.
J Infect Dis
. 2023 May;
228(11):1528-1538.
PMID: 37246724
Background: No overall estimate of respiratory syncytial virus (RSV)-associated hospitalizations in children aged under 5 years has been published for the European Union (EU). We aimed to estimate the RSV...
4.
Teirlinck A, Johannesen C, Broberg E, Penttinen P, Campbell H, Nair H, et al.
Eur Respir J
. 2023 Apr;
61(4).
PMID: 37012081
No abstract available.
5.
Den Hartog G, van Kasteren P, Schepp R, Teirlinck A, van der Klis F, Van Binnendijk R
Lancet Infect Dis
. 2022 Dec;
23(1):23-25.
PMID: 36463892
No abstract available.
6.
Reeves R, Van Wijhe M, Lehtonen T, Stona L, Teirlinck A, Vazquez Fernandez L, et al.
J Infect Dis
. 2022 Mar;
226(Suppl 1):S110-S116.
PMID: 35333332
Background: Since the widespread adoption of palivizumab prophylaxis in Europe, there have been a number of clinical practice guidelines (CPGs) published for the prevention of respiratory syncytial virus (RSV) infection...
7.
Niessen A, Teirlinck A, McDonald S, van der Hoek W, van Gageldonk-Lafeber R, Knol M
Infection
. 2022 Feb;
50(3):709-717.
PMID: 35138581
Introduction: Since the first reports of COVID-19 cases, sex-discrepancies have been reported in COVID-19 mortality. We provide a detailed description of these sex differences in relation to age and comorbidities...
8.
Wang X, Li Y, Vazquez Fernandez L, Teirlinck A, Lehtonen T, Van Wijhe M, et al.
J Infect Dis
. 2022 Jan;
226(Suppl 1):S22-S28.
PMID: 35023567
Background: Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infections (RTIs) in young children. High-quality country-specific estimates of bed days and length of stay (LOS) show the...
9.
Linssen R, Teirlinck A, van Boven M, Biarent D, Stona L, Amigoni A, et al.
J Crit Care
. 2021 Jul;
68:165-168.
PMID: 34304966
Purpose: Viral bronchiolitis is a major cause of pediatric intensive care unit (PICU) admission. Insight in the trends of bronchiolitis-associated PICU admissions is limited, but imperative for future PICU resource...
10.
van Summeren J, Meijer A, Aspelund G, Casalegno J, Erna G, Hoang U, et al.
Euro Surveill
. 2021 Jul;
26(29).
PMID: 34296672
Since the introduction of non-pharmacological interventions to control COVID-19, respiratory syncytial virus (RSV) activity in Europe has been limited. Surveillance data for 17 countries showed delayed RSV epidemics in France...